Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 722074 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
| More
ElectronicAdd to Basket



Auxilium Pharmaceuticals, Inc.
Datamonitor, Sep 2008, Pages: 26


  Description  
  Table of Contents  
    
    
    
   
 Enquire before Buying  
 Send to a Friend  

The Auxilium Pharmaceuticals, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Auxilium Pharmaceuticals (Auxilium) is a specialty biopharmaceutical company engaged in developing and marketing products in the areas of urology, endocrinology and orthopedics. The company markets Testim, a testosterone replacement treatment for hypogonadism, primarily to urologists, endocrinologists, orthopedists and select primary care physicians. Auxilium is headquartered in Malvern, Pennsylvania and employed 300 people as of December 2007. The company recorded revenues of $96 million during the financial year (FY) ended December 2007, an increase of 39.7% over FY2006. The increase was primarily attributable to the substantial demand for Testim resulting from increased prescriptions and increases in pricing, net of discounts, rebates and coupons. The operating loss of the company was $44 million during FY2007, as compared to an operating loss of $48 million in FY2006. The net loss was $41 million in FY2007, as compared to a net loss of $46 million in FY2006.

Scope of the Report

- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available


Customers who bought this item also bought

Auxilium Pharmaceuticals Inc - SWOT Analysis

Premium Company Profile Auxilium Pharmaceuticals

Auxilium Pharmaceuticals, Inc. - Financial and Strategic Analysis Review

Auxilium Pharmaceuticals, Inc. - Company PicShot

Auxilium Pharmaceuticals Inc - SWOT Framework Analysis

Amylin Pharmaceuticals, Inc. - SWOT Analysis

Auxilium Pharmaceuticals, Inc. and Pfizer, Inc Strategic Alliance Agreement Call - Auxilium Pharmaceuticals, Inc., - Earnings Transcript

Auxilium Pharmaceuticals Inc.-Financial Company Report

Isis Pharmaceuticals, Inc. - SWOT Analysis

Noven Pharmaceuticals, Inc. - SWOT Analysis

Amylin Pharmaceuticals, Inc.

Idenix Pharmaceuticals, Inc.



Top of page


   All rights reserved. © Copyright 2009 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds